ArticleBMJ open2019

Effectiveness in clinical practice versus efficacy of dipeptidyl peptidase-4 inhibitors in clinical trials for type 2 diabetes: protocol for systematic review.

Francisco Batel-Marques et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.